Jennifer J. Hitchcock
Partner
Corporate
Jennifer J.
Hitchcock
Jennifer J.
Hitchcock
Partner
Corporate
Jen is a partner in Fenwick’s Capital Markets and Public Companies group advising technology and life sciences clients on capital markets and general public company corporate matters. Jen represents companies and underwriters in a wide range of capital markets transactions, including initial public offerings, direct listings and follow-on offerings in equity and debt. She also represents public companies in securities law compliance and disclosure matters and corporate governance matters.
Jen’s issuer-side initial public offerings include Coinbase (the first Nasdaq direct listing), Cloudera, Fitbit, Nurix Therapeutics, Peloton, Sutro Biopharma and UserTesting. Her underwriter-side initial public offerings include Adaptive Biotechnologies, AppLovin, Impinj, New Relic and Pivotal Software.
Jen has represented multiple public companies in their debt and follow-on equity offerings, including Agilent Technologies, Chegg, Cisco, Cloudera, Coinbase, Corium, Dermira, Fitbit, Nurix Therapeutics, Peloton and Veracyte.
Jen was recognized in 2023 as a leading lawyer in Capital Markets: Equity Offerings by The Legal 500, and Law360 named her as a “Rising Star for Capital Markets” in 2022.
Prior to joining Fenwick, Jen received her J.D. from the University of California, Berkely School of Law where she was a member of the Order of the Coif.
- UserTesting initial public offering
- Coinbase direct listing and convertible senior notes offering
- Nurix Therapeutics initial public offering and follow-on public offering
- Peloton initial public offering and convertible senior notes offering
- Sutro Biopharma initial public offering
- Cloudera initial public offering and follow-on public offering
- Fitbit initial public offering and follow-on public offering
- Chegg follow-on public offering and convertible senior notes offering
- Dermira multiple follow-on public offerings and convertible senior notes offering
- Corium International multiple follow-on public offerings
- Veracyte follow-on public offering
- Agilent Technologies senior notes offering
- Cisco senior notes offering
- AppLovin initial public offering*
- Pivotal Software initial public offering*
- Adaptive Biotechnologies initial public offering and follow-on public offerings*
- Impinj initial public offering, follow-on public offering and convertible senior notes offering*
- New Relic initial public offering*
*Representing the representatives on behalf of the underwriters/initial purchasers, including such investment banks as Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities, RBC Capital Markets, Allen & Company, Pacific Crest Securities, a division of KeyBanc Capital Markets, Piper Jaffray, and UBS Securities, among others.
- UserTesting initial public offering
- Coinbase direct listing and convertible senior notes offering
- Nurix Therapeutics initial public offering and follow-on public offering
- Peloton initial public offering and convertible senior notes offering
- Sutro Biopharma initial public offering
- Cloudera initial public offering and follow-on public offering
- Fitbit initial public offering and follow-on public offering
- Chegg follow-on public offering and convertible senior notes offering
- Dermira multiple follow-on public offerings and convertible senior notes offering
- Corium International multiple follow-on public offerings
- Veracyte follow-on public offering
- Agilent Technologies senior notes offering
- Cisco senior notes offering
- AppLovin initial public offering*
- Pivotal Software initial public offering*
- Adaptive Biotechnologies initial public offering and follow-on public offerings*
- Impinj initial public offering, follow-on public offering and convertible senior notes offering*
- New Relic initial public offering*
*Representing the representatives on behalf of the underwriters/initial purchasers, including such investment banks as Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities, RBC Capital Markets, Allen & Company, Pacific Crest Securities, a division of KeyBanc Capital Markets, Piper Jaffray, and UBS Securities, among others.
- Coinbase
- Goldman Sachs
- JP Morgan
- Morgan Stanley
- Nurix Therapeutics
- Pardes Biosciences
- Shockwave Medical
- The Arena Group
- UserTesting
- Coinbase
- Goldman Sachs
- JP Morgan
- Morgan Stanley
- Nurix Therapeutics
- Pardes Biosciences
- Shockwave Medical
- The Arena Group
- UserTesting
Recognition Recognition Recognition
Recognition Recognition Recognition
Law360
2022
Named Jen a Law360 Rising Star for Capital Markets.
The Legal 500
2023
The Legal 500 recognized Jennifer as a leading lawyer in Capital Markets: Equity Offerings.
Law360
2022
Named Jen a Law360 Rising Star for Capital Markets.
The Legal 500
2023
The Legal 500 recognized Jennifer as a leading lawyer in Capital Markets: Equity Offerings.